Gelteq Limited (NASDAQ:GELS) Short Interest Update
by Scott Moore · The Cerbat GemGelteq Limited (NASDAQ:GELS – Get Free Report) was the target of a large growth in short interest in May. As of May 15th, there was short interest totaling 120,948 shares, a growth of 224.2% from the April 30th total of 37,312 shares. Based on an average daily trading volume, of 274,919 shares, the short-interest ratio is presently 0.4 days. Currently, 1.1% of the shares of the company are sold short.
Gelteq Stock Up 8.7%
Gelteq stock traded up $0.04 during mid-day trading on Friday, reaching $0.49. The company’s stock had a trading volume of 60,107 shares, compared to its average volume of 190,718. The firm’s fifty day moving average price is $0.61 and its two-hundred day moving average price is $0.80. Gelteq has a 12-month low of $0.39 and a 12-month high of $3.51.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings lowered shares of Gelteq from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, May 7th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.
Get Our Latest Stock Analysis on Gelteq
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Gelteq stock. Susquehanna International Group LLP purchased a new stake in Gelteq Limited (NASDAQ:GELS – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 41,550 shares of the company’s stock, valued at approximately $57,000. Susquehanna International Group LLP owned 0.44% of Gelteq at the end of the most recent reporting period.
Gelteq Company Profile
Gelteq Inc is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition. Gelteq Inc is based in NEW YORK.